(+)-Rolipram is a selective PDE4 inhibitor with an IC50 of 0.75 µM against the human monocyte enzyme. This compound exhibits anti-inflammatory and CNS antidepressant activities in research models, though it is less potent than its (R)-enantiomer. It is widely used in vitro and in vivo to study PDE4 biology and inflammation-related pathways.